Chimerix Inc (NASDAQ:CMRX) Announces Phase Three Trial Results of Brincidofovir

Chimerix Inc (NASDAQ:CMRX), a sought after biopharmaceutical company active in the production of novel antiviral to cure diseases that need unmet medical attention, announced results of Phase III trials of Brincidofovir. As per the reports, the top-line results show that the trials in the hematopoietic cell transplantation patients didn’t achieve their endpoint. Insights of The […]

Time to Face the Ebola Virus Head-On Instead of using Quarantines: Dr. Scott Gottlieb

Boston, MA 10/16/2014 (wallstreetpr) – The Ebola virus is slowly spreading like wild fire as schools in Dallas close down of fear of the virus spreading even further. Having already killed 4,000 people in West Africa, the World Health Organization is warning that that the virus could get out of hand. During an interview on […]

Biotech Stocks Surging After Second Ebola Case in The U.S.

Boston, MA 10/15/2014 (wallstreetpr) – The preparedness of U.S hospitals more so health care workers is being questioned after a second nurse who had attended to the deceased Eric Thomas Duncan was diagnosed with the virus. The news has already seen biotech companies in the fight against the disease recover losses registered yesterday in the […]

Ebola Fears: Drug And Suit Makers Up In The Market

Boston, MA 10/13/2014 (wallstreetpr) – The Ebola menace is slowly finding its way in the U.S. after a nurse who cared for an Ebola patient was also diagnosed with the virus. Companies developing cures for the diseases lead by Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR) and Sarepta Therapeutics Inc. (NASDAQ:SRPT) have been on an upward swing. Focus […]

Why Chimerix Inc (NASDAQ:CMRX)’s Shares Plunged?

Boston, MA 10/09/2014 (wallstreetpr) – Chimerix Inc (NASDAQ:CMRX) shares ended Wednesday’s trading session in red as a patient in Dallas who was undergoing the experimental treatment of Chimerix for Ebola died. It is a big disappointment for Chimerix as it received the FDA approval for treating Thomas Duncan on Tuesday. He was just started with […]

Losing Stocks: Chimerix Inc (NASDAQ:CMRX), Sears Holdings Corp (NASDAQ:SHLD), Interface, Inc. (NASDAQ:TILE)

Boston, MA 10/09/2014 (wallstreetpr) – 8th October saw investors reducing their exposure to drug maker Chimerix Inc (NASDAQ:CMRX) shares, after news trickled out that a patient who was suspected to be suffering from Ebola died at a Texas Health Presbyterian Hospital. The patient Thomas Duncan had been administered an experimental Ebola treating drug developed by […]

Pre-Market Buzzers: Chimerix Inc (NASDAQ:CMRX), Symantec Corporation (NASDAQ:SYMC), SolarCity Corp (NASDAQ:SCTY)

Boston, MA 10/08/2014 (wallstreetpr) – Chimerix Inc (NASDAQ:CMRX) is raking in mullah as its drug has suddenly become the medicine of choice for Ebola. Ever since the biotechnology company’s antiviral drug ‘brincidofovir’ was used to treat both the NBC News cameraman in Nebraska and the Liberian patient in Dallas on an emergency basis, Chimerix is […]

Chimerix Inc. (NASDAQ:CMRX) Surging After FDA Approval Of Its Pill, To Save A Dying Baby

Boston, MA 03/14/2014 (wallstreetpr) – Chimerix Inc. (NASDAQ:CMRX)’s stock has been rising in the market by as much as 18.2% after the company received an approval from the FDA, for the use of one of its pill to try and save the life a 7 year old boy who is suffering from a viral infection. […]